4.2 Article

CamMedNP: Building the Cameroonian 3D structural natural products database for virtual screening

期刊

出版社

BIOMED CENTRAL LTD
DOI: 10.1186/1472-6882-13-88

关键词

3D structures; Database collection; Natural products; Medicinal plants; Virtual screening

资金

  1. German Academic Exchange Service (DAAD)

向作者/读者索取更多资源

Background: Computer-aided drug design (CADD) often involves virtual screening (VS) of large compound datasets and the availability of such is vital for drug discovery protocols. We present CamMedNP - a new database beginning with more than 2,500 compounds of natural origin, along with some of their derivatives which were obtained through hemisynthesis. These are pure compounds which have been previously isolated and characterized using modern spectroscopic methods and published by several research teams spread across Cameroon. Description: In the present study, 224 distinct medicinal plant species belonging to 55 plant families from the Cameroonian flora have been considered. About 80 % of these have been previously published and/or referenced in internationally recognized journals. For each compound, the optimized 3D structure, drug-like properties, plant source, collection site and currently known biological activities are given, as well as literature references. We have evaluated the drug-likeness of this database using Lipinski's Rule of Five. A diversity analysis has been carried out in comparison with the ChemBridge diverse database. Conclusion: CamMedNP could be highly useful for database screening and natural product lead generation programs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic Activity

Hany S. Ibrahim, Mohamed Abdelsalam, Yanira Zeyn, Matthes Zessin, Al-Hassan M. Mustafa, Marten A. Fischer, Patrik Zeyen, Ping Sun, Emre F. Buelbuel, Anita Vecchio, Frank Erdmann, Matthias Schmidt, Dina Robaa, Cyril Barinka, Christophe Romier, Mike Schutkowski, Oliver H. Kraemer, Wolfgang Sippl

Summary: In this study, a novel series of selective Class I HDAC inhibitors were synthesized and tested in vitro and in vivo. The most potent compound showed strong inhibitory effects and potential for treating various types of blood cancer cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Chemistry, Medicinal

Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis

Ehab Ghazy, Mohamed Abdelsalam, Dina Robaa, Raymond J. Pierce, Wolfgang Sippl

Summary: This review focuses on the recent development of inhibitors for schistosome histone deacetylases, particularly inhibitors of Schistosoma mansoni histone deacetylase 8, which have shown promise for the treatment of schistosomiasis.

PHARMACEUTICALS (2022)

Article Biochemistry & Molecular Biology

Uncovering Robust Delactoylase and Depyruvoylase Activities of HDAC Isoforms

Matthes Zessin, Marat Meleshin, Lucas Praetorius, Wolfgang Sippl, Cyril Barinka, Mike Schutkowski

Summary: This study systematically analyzed the acyl-specificity of human zinc-dependent HDAC and sirtuin isoforms. The results showed that HDAC3 has a much higher delactoylase activity compared to SIRT2, which was previously believed to be the major in vivo delactoylase. Additionally, HDAC6 and HDAC8 were found to have high depyruvoylase activity.

ACS CHEMICAL BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Finding alternatives to 5-fluorouracil: application of ensemble-based virtual screening for drug repositioning against human thymidylate synthase

Denis Mteremko, Daniel M. Shadrack, Fidele Ntie-Kang, Jaffu Chilongola, Musa Chacha

Summary: 5-fluorouracil and analogs are commonly used in chemotherapy for solid tumors, but resistance and toxicity are common. Repurposing FDA drugs targeting human thymidylate synthase identified several drugs with potential for further development in cancer treatment. The study prioritized four FDA drugs (Erismodegib, Irinotecan, Conivaptan, and Ergotamine) for validation. The role of water in drug interactions and its contribution to binding energy was also explored.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Article Chemistry, Medicinal

Development of New Inhibitors of HDAC1-3 Enzymes Aided by In Silico Design Strategies

Narges Cheshmazar, Salar Hemmati, Maryam Hamzeh-Mivehroud, Babak Sokouti, Matthes Zessin, Mike Schutkowski, Wolfgang Sippl, Hojjatollah Nozad Charoudeh, Siavoush Dastmalchi

Summary: Histone deacetylases (HDACs), which are overexpressed in cancer, have shown promising results in cancer therapy when inhibited. This study used computational drug design to generate and filter potential HDAC inhibitors based on template structures and a diverse fragment library. Two new structures (3a and 3b) were proposed for synthesis and evaluation, and the compounds showed inhibition on HDAC isoforms.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2022)

Article Biochemistry & Molecular Biology

Docking, Binding Free Energy Calculations and In Vitro Characterization of Pyrazine Linked 2-Aminobenzamides as Novel Class I Histone Deacetylase (HDAC) Inhibitors

Emre F. Bulbul, Jelena Melesina, Hany S. Ibrahim, Mohamed Abdelsalam, Anita Vecchio, Dina Robaa, Matthes Zessin, Mike Schutkowski, Wolfgang Sippl

Summary: In this study, a computational approach was used to predict the selectivity of inhibitors targeting HDAC1, HDAC2, and HDAC3. The developed binding free-energy models showed significant correlation between binding free energy and in vitro inhibitory activities, and successfully predicted the efficacy of newly designed inhibitors.

MOLECULES (2022)

Article Biochemistry & Molecular Biology

Small Changes Make the Difference for SIRT2: Two Different Binding Modes for 3-Arylmercapto-Acylated Lysine Derivatives

Diana Kalbas, Marat Meleshin, Sandra Liebscher, Matthes Zessin, Jelena Melesina, Cordelia Schiene-Fischer, Emre Fatih Bu''lbu''l, Frank Bordusa, Wolfgang Sippl, Mike Schutkowski

Summary: Sirtuins are protein deacylases involved in regulating metabolism, stress responses, and aging-related diseases. In this study, we synthesized and characterized 3-aryl-mercaptobutyrylated peptide derivatives as effective and selective Sirtuin 2 inhibitors. Our findings suggest that these inhibitors bind to the selectivity pocket of Sirtuin 2, inducing a rearrangement of the active site. Interestingly, 3-aryl-mercapto-nonalyl or palmitoyl derivatives exhibited a different binding mode, blocking both the hydrophobic channel and the nicotinamide pocket.

BIOCHEMISTRY (2022)

Article Plant Sciences

The International Natural Product Sciences Taskforce (INPST) and the power of Twitter networking exemplified through #INPST hashtag analysis

Rajeev K. Singla, Ronita De, Thomas Efferth, Bruno Mezzetti, Md Sahab Uddin, Sanusi, Fidele Ntie-Kang, Dongdong Wang, Fabien Schultz, Kiran R. Kharat, Hari Prasad Devkota, Maurizio Battino, Daniel Sur, Ronan Lordan, Sourav S. Patnaik, Christos Tsagkaris, Chandragiri Siva Sai, Surya Kant Tripathi, Mihnea-Alexandru Gaman, Mosa E. O. Ahmed, Elena Gonzalez-Burgos, Smith B. Babiaka, Shravan Kumar Paswan, Joy Ifunanya Odimegwu, Faizan Akram, Jesus Simal-Gandara, Magali S. Urquiza, Aleksei Tikhonov, Himel Mondal, Shailja Singla, Sara Di Lonardo, Eoghan J. Mulholland, Merisa Cenanovic, Abdulkadir Yusif Maigoro, Francesca Giampieri, Soojin Lee, Nikolay T. Tzvetkov, Anna Maria Louka, Pritt Verma, Hitesh Chopra, Scarlett Perez Olea, Johra Khan, Jose M. Alvarez Suarez, Xiaonan Zheng, Michal Tomczyk, Manoj Kumar Sabnani, Christhian Delfino Villanueva Medina, Garba M. Khalid, Hemanth Kumar Boyina, Milen Georgiev, Claudiu T. Supuran, Eduardo Sobarzo-Sanchez, Tai-Ping Fan, Valeria Pittala, Antoni Sureda, Nady Braidy, Gian Luigi Russo, Rosa Anna Vacca, Maciej Banach, Gerard Lizard, Amira Zarrouk, Sonia Hammami, Ilkay Erdogan Orhan, Bharat B. Aggarwal, George Perry, Mark J. S. Miller, Michael Heinrich, Anupam Bishayee, Anake Kijjoa, Nicolas Arkells, David Bredt, Michael Wink, Bernd L. Fiebich, Gangarapu Kiran, Andy Wai Kan Yeung, Girish Kumar Gupta, Antonello Santini, Massimo Lucarini, Alessandra Durazzo, Amr El-Demerdash, Albena T. Dinkova-Kostova, Alejandro Cifuentes, Eliana B. Souto, Muhammad Asim Masoom Zubair, Pravin Badhe, Javier Echeverria, Jaroslaw Olav Horbanczuk, Olaf K. Horbanczuk, Helen Sheridan, Sadeeq Muhammad Sheshe, Anna Maria Witkowska, Ibrahim M. Abu-Reidah, Muhammad Riaz, Hammad Ullah, Akolade R. Oladipupo, Victor Lopez, Neeraj Kumar Sethiya, Bhupal Govinda Shrestha, Palaniyandi Ravanan, Subash Chandra Gupta, Qushmua E. Alzahrani, Preethidan Dama Sreedhar, Jianbo Xiao, Mohammad Amin Moosavi, Parasuraman Aiya Subramani, Amit Kumar Singh, Ananda Kumar Chettupalli, Jayanta Kumar Patra, Gopal Singh, Tomasz M. Karpinski, Fuad Al-Rimawi, Rambod Abiri, Atallah F. Ahmed, Davide Barreca, Sharad Vats, Said Amrani, Carmela Fimognari, Andrei Mocan, Lucian Hritcu, Prabhakar Semwal, Md Shiblur Rahaman, Mila Emerald, Akinleye Stephen Akinrinde, Abhilasha Singh, Ashima Joshi, Tanuj Joshi, Shafaat Yar Khan, Gareeballah Osman Adam Balla, Aiping Lu, Sandeep Ramchandra Pai, Imen Ghzaiel, Niyazi Acar, Nour Eddine Es-Safi, Gokhan Zengin, Azazahemad A. Kureshi, Arvind Kumar Sharma, Bikash Baral, Neeraj Rani, Philippe Jeandet, Monica Gulati, Bhupinder Kapoor, Yugal Kishore Mohanta, Zahra Emam-Djomeh, Raphael Onuku, Jennifer R. Depew, Omar M. Atrooz, Bey Hing Goh, Jose Carlos Andrade, Bikramjit Konwar, V. J. Shine, Joao Miguel Lousa Dias Ferreira, Jamil Ahmad, Vivek K. Chaturvedi, Krystyna Skalicka-Wozniak, Rohit Sharma, Rupesh K. Gautam, Sebastian Granica, Salvatore Parisi, Rishabh Kumar, Atanas G. Atanasov, Bairong Shen

Summary: The development of digital technologies and open innovation approaches has enabled the creation of virtual organizations and enterprises. The International Natural Product Sciences Taskforce (INPST) is an open innovation platform that brings together individuals and organizations interested in natural product scientific research. This study presents an overview of INPST activities and showcases the use of Twitter as a powerful networking tool, demonstrated through the 2021 INPST Twitter Networking Event.

PHYTOMEDICINE (2023)

Editorial Material Biochemistry & Molecular Biology

Editorial for Special Issue-Early-Stage Drug Discovery: Advances and Challenges

Wolfgang Sippl

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Chemistry, Medicinal

Design and synthesis of bioreductive prodrugs of class I histone deacetylase inhibitors and their biological evaluation in virally transfected acute myeloid leukemia cells

Mohamed Abdelsalam, Mariia Zmyslia, Karin Schmidtkunz, Anita Vecchio, Sebastian Hilscher, Hany S. Ibrahim, Mike Schutkowski, Manfred Jung, Claudia Jessen-Trefzer, Wolfgang Sippl

Summary: In this study, a series of prodrugs for class I histone deacetylases (HDACs) were designed and synthesized using known selective HDAC inhibitors. Compound 6 showed the most potent inhibitory activity against nitroreductase (NTR)-transfected leukemic cells.

ARCHIV DER PHARMAZIE (2023)

Article Oncology

NOXA Accentuates Apoptosis Induction by a Novel Histone Deacetylase Inhibitor

Ramy Ashry, Al-Hassan M. Mustafa, Kristin Hausmann, Michael Linnebacher, Susanne Strand, Wolfgang Sippl, Matthias Wirth, Oliver H. Kraemer

Summary: Tumors in the pancreas and colon are still a clinical challenge. Different gene expression profiles between cancer cells and normal cells can be targeted by drugs that modulate protein acetylation. KH16 is a novel compound that induces hyperacetylation, leading to cell death in tumor cells while sparing normal cells. It shows superior efficacy compared to clinically established drugs. Further studies can focus on KH16 and similar compounds for cancer therapy.

CANCERS (2023)

Article Chemistry, Medicinal

Application of Ligand- and Structure-Based Prediction Models for the Design of Alkylhydrazide-Based HDAC3 Inhibitors as Novel Anti-Cancer Compounds

Emre F. F. Buelbuel, Dina Robaa, Ping Sun, Fereshteh Mahmoudi, Jelena Melesina, Matthes Zessin, Mike Schutkowski, Wolfgang Sippl

Summary: This study analyzed different ligand-based and structure-based drug design techniques to predict the binding mode and inhibitory activity of recently developed alkylhydrazide HDAC inhibitors. Alkylhydrazides have shown promising effects in various cancer cell lines. The created models, including pharmacophore models and atom-based quantitative structure-activity relationship (QSAR) models, explain in vitro data well and were used to develop novel HDAC3 inhibitors.

PHARMACEUTICALS (2023)

Article Biology

Utilization of AlphaFold models for drug discovery: Feasibility and challenges. Histone deacetylase 11 as a case study

Fady Baselious, Dina Robaa, Wolfgang Sippl

Summary: In this study, we optimized the HDAC11 AlphaFold model by adding the catalytic zinc ion and successfully generated stable complexes for docking of selective inhibitors. The most reasonable pose was selected based on structural comparison, and the model explained the binding behavior of known HDAC11 inhibitors.

COMPUTERS IN BIOLOGY AND MEDICINE (2023)

Review Chemistry, Multidisciplinary

Challenges in natural product-based drug discovery assisted with in silico-based methods

Conrad V. Simoben, Smith B. Babiaka, Aurelien F. A. Moumbock, Cyril T. Namba-Nzanguim, Donatus Bekindaka Eni, Jose L. Medina-Franco, Stefan Guenther, Fidele Ntie-Kang, Wolfgang Sippl

Summary: The use of traditional medicine has a long history and is still relied upon by many, especially in developing or underprivileged communities. In silico-based methods have played a crucial role in drug discovery, particularly in identifying natural product-based candidates. However, there are challenges in identifying and proposing novel natural product-based hits.

RSC ADVANCES (2023)

暂无数据